Singh, Siddharth

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis

Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 1,965

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

Singh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 1,748

Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis

Khera, R., Murad, M. H., Chandar, A. K., Dulai, P. S., Wang, Z., Prokop, L. J., Loomba, R., Camilleri, M., & Singh, S. (2016) · JAMA

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 865

Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis

Klem, F., Wadhwa, A., Prokop, L. J., Sundt, W. J., Farrugia, G., Camilleri, M., Singh, S., & Grover, M. (2017) · Gastroenterology

Gastrointestinal motility and disordersGut microbiota and health

Cited by 474

AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity

Grunvald, E., Shah, R., Hernaez, R., Chandar, A. K., Pickett-Blakely, O., Teigen, L. M., Harindhanavudhi, T., Sultan, S., Singh, S., & Davitkov, P. (2022) · Gastroenterology

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 347

Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis

Singh, S., Garg, S. K., Singh, P. P., Iyer, P. G., & El-Serag, H. B. (2014) · Gut

Esophageal Cancer Research and TreatmentGastroesophageal reflux and treatments

Cited by 298

Incidence, risk factors, and outcomes of colorectal cancer in patients with ulcerative colitis with low-grade dysplasia: a systematic review and meta-analysis

Fumery, M., Dulai, P. S., Gupta, S., Prokop, L. J., Ramamoorthy, S., Sandborn, W. J., & Singh, S. (2017) · Clinical Gastroenterology and Hepatology

Inflammatory Bowel DiseaseColorectal Cancer Screening and Detection

Cited by 161

Primary sclerosing cholangitis: diagnosis, prognosis, and management

Singh, S., & Talwalkar, J. A. (2013) · Clinical Gastroenterology and Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 119

Effect of Ursodeoxycholic Acid Use on the Risk of Colorectal Neoplasia in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Singh, S., Khanna, S., Pardi, D. S., Loftus, E. V., & Talwalkar, J. A. (2013) · Inflammatory Bowel Diseases

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 94

Systematic review with network meta-analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH

Majzoub, A. M., Nayfeh, T., Barnard, A., Munaganuru, N., Dave, S., Singh, S., Murad, M. H., & Loomba, R. (2021) · Alimentary Pharmacology & Therapeutics

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 92

Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease

Christensen, B., Micic, D., Gibson, P. R., Yarur, A., Bellaguarda, E., Corsello, P., Gaetano, J. N., Kinnucan, J., Rao, V. L., Reddy, S., et al. (2018) · Alimentary Pharmacology & Therapeutics

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 91

Effects of weight-loss medications on cardiometabolic risk profiles: a systematic review and network meta-analysis

Khera, R., Pandey, A., Chandar, A. K., Murad, M. H., Prokop, L. J., Neeland, I. J., Berry, J. D., Camilleri, M., & Singh, S. (2018) · Gastroenterology

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 90

Genome privacy: challenges, technical approaches to mitigate risk, and ethical considerations in the United States

Wang, S., Jiang, X., Singh, S., Marmor, R., Bonomi, L., Fox, D., Dow, M., & Ohno‐Machado, L. (2017) · Annals of the New York Academy of Sciences

Privacy-Preserving Technologies in DataEthics in Clinical Research

Cited by 78

An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials

Almradi, A., Ma, C., D'Haens, G. R., Sandborn, W. J., Parker, C. E., Guizzetti, L., Borralho Nunes, P., De Hertogh, G., Feakins, R. M., Khanna, R., et al. (2021) · Alimentary Pharmacology & Therapeutics

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 34

Addition of Financial Incentives to Mailed Outreach for Promoting Colorectal Cancer Screening: A Systematic Review and Meta-analysis

Facciorusso, A., Demb, J., Mohan, B. P., Gupta, S., & Singh, S. (2021) · JAMA Network Open

Colorectal Cancer Screening and DetectionGlobal Cancer Incidence and Screening

Cited by 26

Impact of comorbid psychiatric disorders on healthcare utilization in patients with inflammatory bowel disease: A nationally representative cohort study

Hill, E., Nguyen, N. H., Qian, A. S., Patel, S., Chen, P. L., Tse, C.-S., & Singh, S. (2022) · Digestive Diseases and Sciences

Inflammatory Bowel DiseaseMental Health Treatment and Access

Cited by 15

A Framework for Clinical Trials of Neurobiological Interventions That Target the Gut-Brain Axis in Inflammatory Bowel Disease

Tse, C. S., Singh, S., & Sandborn, W. J. (2022) · Inflammatory Bowel Diseases

Inflammatory Bowel DiseaseStatistical Methods in Clinical Trials

Cited by 3